– Philips reinforces its leadership in innovation and technology, showcases solutions that increase workflow, consistency and confidence in cancer treatment
ANDOVER, Mass., Sept. 13, 2014 /PRNewswire/ — Royal Philips (NYSE: PHG AEX: PHIA) today announced a number of innovations at ASTRO’s 56th Annual Meeting in San Francisco, showcasing solutions that increase workflow automation, confidence, consistency and accuracy in cancer treatment. Producing quality results in less time and enhancing patient-centric care, these radiation oncology solutions underscore Philips’ dedication to leading healthcare into an era of a more personalized approach to medicine.
"Philips is leveraging our expertise in CT, MR and treatment planning to provide integrated oncology solutions. We believe the use of advanced imaging like MR, tailored to the needs of radiation oncology, is going to help create a healthier future for cancer patients and those who direct their care," said Gene Saragnese, CEO Imaging Systems, Philips.
The Philips booth (#1128) at ASTRO 2014 will showcase the company’s expanding oncology presence with a suite of options for physicians and clinicians to target various cancers and improve care for patients. Key product offerings highlighted at ASTRO include:
- Pinnacle3 Auto-Planning – Pinnacle³ Auto-Planning is designed to simplify and accelerate IMRT & VMAT planning. It has smart automation tools that enable the user to generate high quality plans quickly, and with limited intervention. These plans can then be evaluated against agreed clinical goals using intuitive dashboards, called Scorecards that provide at-a-glance information regarding plan quality, facilitating consistency of treatments throughout the department.
- iPatient Platform for Brilliance CT Big Bore– Philips is continuing to focus on innovations that facilitate patient-centered imaging by expanding its advanced iPatient platform to the Brilliance CT Big Bore. iPatient puts users in control of innovative solutions that drive confidence and consistency through a personalized, patient-centric workflow. It helps health systems reap more from their investments by allowing users the ability to focus complex and advanced procedures.
- MRI-Only Simulation for Prostate – Philips is designing a plug-in extension to its Ingenia MR-RT Oncology Configuration. The software package is intended to include embedded auto-segmentation and bulk density assignment algorithms to provide CT-like MR images, with the possibility of uploading to treatment planning systems to aid in dose calculations. The first application planned is prostate, which is one of the main applications to harness MRI’s soft-tissue contrast for RT planning purposes
For more information on Philips’ presence at ASTRO, including the full suite of Philips enterprise software, solutions and services, visit our ASTRO Event Page and follow the conversation via @PhilipsHealth.
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.